vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and CB Financial Services, Inc. (CBFV). Click either name above to swap in a different company.

CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $8.1M, roughly 1.7× Arcellx, Inc.). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs -79.3%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $-63.9M). Over the past eight quarters, CB Financial Services, Inc.'s revenue compounded faster (1.2% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

ACLX vs CBFV — Head-to-Head

Bigger by revenue
CBFV
CBFV
1.7× larger
CBFV
$13.8M
$8.1M
ACLX
Growing faster (revenue YoY)
CBFV
CBFV
+99.2% gap
CBFV
19.9%
-79.3%
ACLX
More free cash flow
CBFV
CBFV
$81.1M more FCF
CBFV
$17.2M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
CBFV
CBFV
Annualised
CBFV
1.2%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
CBFV
CBFV
Revenue
$8.1M
$13.8M
Net Profit
$-62.3M
Gross Margin
Operating Margin
-847.6%
38.1%
Net Margin
-766.0%
Revenue YoY
-79.3%
19.9%
Net Profit YoY
-765.1%
EPS (diluted)
$-1.13
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
CBFV
CBFV
Q4 25
$13.8M
Q3 25
$2.4M
Q2 25
$13.5M
Q1 25
$8.1M
$12.1M
Q4 24
$15.3M
$13.2M
Q3 24
$26.0M
$12.7M
Q2 24
$27.4M
$12.2M
Q1 24
$39.3M
$13.5M
Net Profit
ACLX
ACLX
CBFV
CBFV
Q4 25
Q3 25
$-5.7M
Q2 25
$3.9M
Q1 25
$-62.3M
$1.9M
Q4 24
$-47.1M
Q3 24
$-25.9M
$3.2M
Q2 24
$-27.2M
$2.6M
Q1 24
$-7.2M
$4.2M
Operating Margin
ACLX
ACLX
CBFV
CBFV
Q4 25
38.1%
Q3 25
-289.8%
Q2 25
35.0%
Q1 25
-847.6%
19.3%
Q4 24
-348.2%
23.1%
Q3 24
-129.1%
31.2%
Q2 24
-127.8%
26.4%
Q1 24
-40.3%
37.9%
Net Margin
ACLX
ACLX
CBFV
CBFV
Q4 25
Q3 25
-235.2%
Q2 25
29.3%
Q1 25
-766.0%
15.8%
Q4 24
-308.4%
Q3 24
-99.4%
25.3%
Q2 24
-99.3%
21.8%
Q1 24
-18.3%
31.1%
EPS (diluted)
ACLX
ACLX
CBFV
CBFV
Q4 25
$0.90
Q3 25
$-1.07
Q2 25
$0.74
Q1 25
$-1.13
$0.35
Q4 24
$-0.87
$0.45
Q3 24
$-0.48
$0.60
Q2 24
$-0.51
$0.51
Q1 24
$-0.14
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
CBFV
CBFV
Cash + ST InvestmentsLiquidity on hand
$543.3M
$31.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$157.5M
Total Assets
$648.1M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
CBFV
CBFV
Q4 25
$31.7M
Q3 25
$55.9M
Q2 25
$64.5M
Q1 25
$543.3M
$61.3M
Q4 24
$587.4M
$49.6M
Q3 24
$574.3M
$147.3M
Q2 24
$516.7M
$142.6M
Q1 24
$573.9M
$73.7M
Stockholders' Equity
ACLX
ACLX
CBFV
CBFV
Q4 25
$157.5M
Q3 25
$152.5M
Q2 25
$148.4M
Q1 25
$416.9M
$148.3M
Q4 24
$454.8M
$147.4M
Q3 24
$483.0M
$149.1M
Q2 24
$487.2M
$142.9M
Q1 24
$496.6M
$141.6M
Total Assets
ACLX
ACLX
CBFV
CBFV
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$648.1M
$1.5B
Q4 24
$711.3M
$1.5B
Q3 24
$764.9M
$1.6B
Q2 24
$734.3M
$1.6B
Q1 24
$779.7M
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
CBFV
CBFV
Operating Cash FlowLast quarter
$-63.1M
$17.8M
Free Cash FlowOCF − Capex
$-63.9M
$17.2M
FCF MarginFCF / Revenue
-786.4%
124.1%
Capex IntensityCapex / Revenue
9.6%
4.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
CBFV
CBFV
Q4 25
$17.8M
Q3 25
$4.6M
Q2 25
$4.1M
Q1 25
$-63.1M
$4.0M
Q4 24
$-46.0M
$6.8M
Q3 24
$30.7M
$3.1M
Q2 24
$-36.2M
$-1.2M
Q1 24
$-31.9M
$3.3M
Free Cash Flow
ACLX
ACLX
CBFV
CBFV
Q4 25
$17.2M
Q3 25
$4.5M
Q2 25
$3.9M
Q1 25
$-63.9M
$3.9M
Q4 24
$-47.5M
$3.4M
Q3 24
$28.4M
$2.2M
Q2 24
$-39.5M
$-2.4M
Q1 24
$-38.3M
$2.3M
FCF Margin
ACLX
ACLX
CBFV
CBFV
Q4 25
124.1%
Q3 25
186.5%
Q2 25
28.8%
Q1 25
-786.4%
32.5%
Q4 24
-311.3%
26.0%
Q3 24
109.2%
17.4%
Q2 24
-144.1%
-19.6%
Q1 24
-97.7%
17.0%
Capex Intensity
ACLX
ACLX
CBFV
CBFV
Q4 25
4.7%
Q3 25
4.3%
Q2 25
1.9%
Q1 25
9.6%
0.8%
Q4 24
9.8%
25.1%
Q3 24
8.8%
6.7%
Q2 24
11.7%
10.0%
Q1 24
16.4%
7.2%
Cash Conversion
ACLX
ACLX
CBFV
CBFV
Q4 25
Q3 25
Q2 25
1.05×
Q1 25
2.11×
Q4 24
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons